HIGHLIGHTS
- who: Ogg and colleagues from the University of Cagliari, Italy have published the paper: Pharmacological OGG1 inhibition decreases murine allergic airway in ammation, in the Journal: (JOURNAL)
- what: The authors assessed the potential therapeutic use of TH5487 in a mouse model of allergen-induced airway inflammation. The aim of this study was to evaluate the treatment potential of a small_molecule inhibitor of OGG1 frontiersin.org 10.3389/fphar.2022.999180 paraformaldehyde solution (4%).
- future: A limitation of this study is whether treatment of allergic asthma with TH5487 is feasible in humans for which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.